These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18837148)

  • 1. [The inhibition of the c-Myc gene: a step toward an almost universal therapy of cancer?].
    Larsen CJ
    Bull Cancer; 2008 Sep; 95(9):797-8. PubMed ID: 18837148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment based on biological characteristics of lung cancer: biological differences between small cell and non-small cell lung cancer and gene therapy].
    Tanio Y
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():337-44. PubMed ID: 9369905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogene addiction: sometimes a temporary slavery.
    Jonkers J; Berns A
    Cancer Cell; 2004 Dec; 6(6):535-8. PubMed ID: 15607957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for lung cancer.
    Toloza EM
    Semin Thorac Cardiovasc Surg; 2005; 17(3):205-12. PubMed ID: 16253824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International symposium on new leads in experimental and clinical gene targeting in cancer.
    Zänker KS; Brentani R; Mihich E
    J Cancer Res Clin Oncol; 2003 Apr; 129(4):258-61. PubMed ID: 12687352
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiation-induced gene therapy.
    Greco O; Marples B; Wilson GD; Joiner MC; Scott SD
    Radiat Res; 2005 Jun; 163(6):707-8. PubMed ID: 16044508
    [No Abstract]   [Full Text] [Related]  

  • 7. [Gene therapy in lung cancer].
    Ran P; Li D; Chen S; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):270-3. PubMed ID: 8762478
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of non-small cell lung cancer cell proliferation and tumor growth by vector-based small interfering RNAs targeting HER2/neu.
    Ren XL; Xu YM; Bao W; Fu HJ; Wu CG; Zhao Y; Li ZK; Zhang J; Li SQ; Chen WQ; Wang T; Zhang R; Zhang LH; Qian GS; Chen SY; Jia LT; Yang AG
    Cancer Lett; 2009 Aug; 281(2):134-43. PubMed ID: 19339104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gene therapy and cancer].
    Mortensen S; Sørensen SB; Poulsen HS
    Ugeskr Laeger; 2002 Mar; 164(13):1785-90. PubMed ID: 11957435
    [No Abstract]   [Full Text] [Related]  

  • 10. Turning on tumors to study cancer progression.
    Berns A
    Nat Med; 1999 Sep; 5(9):989-90. PubMed ID: 10470069
    [No Abstract]   [Full Text] [Related]  

  • 11. Kras and Hras--what is the difference?
    Berns A
    Nat Genet; 2008 Oct; 40(10):1149-50. PubMed ID: 18818716
    [No Abstract]   [Full Text] [Related]  

  • 12. Modification of mutant K-ras gene expression in non-small cell lung cancer (NSCLC).
    Roth JA
    Hum Gene Ther; 1996 May; 7(7):875-89. PubMed ID: 9147520
    [No Abstract]   [Full Text] [Related]  

  • 13. 10-year follow-up of gene-modified adenoviral-based therapy in 146 non-small-cell lung cancer patients.
    Nemunaitis J; Vorhies JS; Pappen B; Senzer N
    Cancer Gene Ther; 2007 Aug; 14(8):762-3. PubMed ID: 17514194
    [No Abstract]   [Full Text] [Related]  

  • 14. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Advances in gene therapy for lung cancer].
    Zhang LQ; Chen HW
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jun; 27(6):430-2. PubMed ID: 15256104
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
    Papadopoulos N; Kinzler KW; Vogelstein B
    Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.
    Wang SL; Yao HH; Guo LL; Dong L; Li SG; Gu YP; Qin ZH
    Cancer Genet Cytogenet; 2009 Apr; 190(1):8-14. PubMed ID: 19264227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic NK4 gene therapy inhibits tumor growth and metastasis of melanoma and lung carcinoma in syngeneic mouse tumor models.
    Kishi Y; Kuba K; Nakamura T; Wen J; Suzuki Y; Mizuno S; Nukiwa T; Matsumoto K; Nakamura T
    Cancer Sci; 2009 Jul; 100(7):1351-8. PubMed ID: 19438869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical development of T cell receptor gene therapy.
    Bendle GM; Haanen JB; Schumacher TN
    Curr Opin Immunol; 2009 Apr; 21(2):209-14. PubMed ID: 19321326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.